Krystal Biotech (KRYS) Net Margin (2017 - 2026)
Krystal Biotech (KRYS) posted Net Margin of 49.53% for Q3 2026, down 31.62 percentage points from 81.15% a year earlier but up 3.59 percentage points from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) Net Margin (2017 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Net Margin at Krystal Biotech was 47.90%, down 5.40 percentage points year-over-year; for FY2025, it was 52.64%, up 21.95 percentage points from FY2024.
- In prior years, Krystal Biotech's Net Margin was 30.69% in FY2024 (+9.13 pp) and 21.56% in FY2023.
- Quarterly Net Margin has run from a low of 2.06% in Q1 2024 to a high of 943.75% in Q3 2023 over five years.
- On a year-over-year basis, Net Margin increased in six of the last eight quarters, with an average year-over-year change of +14.28 percentage points.
- The strongest year-over-year quarter for Net Margin in the past five years was Q3 2025, with a gain of 48.73 percentage points; the weakest was Q3 2024, with a drop of 911.33 percentage points.
- According to Business Quant data, Net Margin for the three prior quarters was 45.94% (Q2 2026), 48.05% (Q1 2026) and 47.99% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 19.55% |
| 10 | Krystal Biotech | 9.08 Bn | 5.67 Bn | 119.79 Mn | 49.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 49.53% |
| Jun 30, 2026 | 45.94% |
| Mar 31, 2026 | 48.05% |
| Dec 31, 2025 | 47.99% |
| Sep 30, 2025 | 81.15% |
| Jun 30, 2025 | 39.91% |
| Mar 31, 2025 | 40.51% |
| Dec 31, 2024 | 49.91% |
| Sep 30, 2024 | 32.42% |
| Jun 30, 2024 | 22.15% |
| Mar 31, 2024 | 2.06% |
| Dec 31, 2023 | 20.62% |
| Sep 30, 2023 | 943.75% |
| Jun 30, 2022 | -4,357.83% |
| Mar 31, 2022 | -19,441.63% |
| Dec 31, 2021 | -31,151.43% |
| Sep 30, 2021 | -24,744.44% |
| Jun 30, 2021 | -54,543.33% |
| Mar 31, 2021 | -47,915.15% |
| Dec 31, 2020 | -28,062.16% |
API Access
Krystal Biotech Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();